Clinical trials
Completed Appendiceal Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 3 |
| 2002 | 2 |
| 2003 | 3 |
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 40 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 7 |
| Wake Forest University Health Sciences | 5 |
| Dartmouth-Hitchcock Medical Center | 2 |
| M.D. Anderson Cancer Center | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| NYU Langone Health | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Albert Einstein College of Medicine | 1 |
| Case Comprehensive Cancer Center | 1 |
| Cybrexa Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Appendiceal Neoplasms | 40 |
| Stomach Neoplasms | 26 |
| Colonic Neoplasms | 24 |
| Pancreatic Neoplasms | 22 |
| Esophageal Neoplasms | 19 |
| Rectal Neoplasms | 19 |
| Gallbladder Neoplasms | 18 |
| Carcinoma, Hepatocellular | 17 |
| Anus Neoplasms | 16 |
| Bile Duct Neoplasms | 16 |
Trials
Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.